(redirected from exacts)
Also found in: Dictionary, Thesaurus.
Related to exacts: extortionate

exact (something) from (one)

To obtain something from someone through authority, force, or some other means of coercion. I doubt you'll be able to exact the entire amount from her because she doesn't make enough money to pay you back right now.
See also: exact

to be (more) exact

To be more accurate; to provide better or more correct details. You'll need to pay nearly $500 for various entry visas to get into the country—$485, to be exact. It seems like the political party is finally starting to gain some amount of clout in parliament, or, to be more exact, they have become less marginalized and disliked.
See also: exact, to
Farlex Dictionary of Idioms. © 2015 Farlex, Inc, all rights reserved.

exact something from someone

to demand something from someone; to take something from someone. The bill collector sought to exact payment from them for a debt that had been paid off long ago. You cannot exact a single cent from me.
See also: exact
McGraw-Hill Dictionary of American Idioms and Phrasal Verbs. © 2002 by The McGraw-Hill Companies, Inc.
See also:
References in periodicals archive ?
LabCorp's first payment to EXACT Sciences of $15 million was made upon the signing of the agreement, and the second payment of $15 million will be made upon the commercial launch of PreGen-Plus, which is expected in the first half of 2003.
Mac Mahon continued, "Our agreement with EXACT Sciences is another example of LabCorp's pioneering leadership position in molecular diagnostics and our ability to recognize the potential of DNA-based testing.
"As the first DNA-based test that will be used for population-based cancer screening, PreGen-Plus truly changes the molecular diagnostics landscape," said Don Hardison, EXACT Sciences' President and CEO.
EXACT Sciences Corporation is an applied genomics company that has developed proprietary technologies that may be used for the early detection of several common cancers.
The growth in these expenses is largely due to costs associated with EXACT Sciences' multi-center clinical study of its PreGen-Plus(TM) technology in an asymptomatic, average-risk population that began in the second half of 2001.
As of March 31, 2002, EXACT Sciences had approximately $50 million in cash and cash equivalents on its balance sheet.
"First quarter 2002 marked important events for EXACT Sciences in research, clinical and marketing," remarked Don Hardison, EXACT Sciences' president and CEO.
Commercial: EXACT Sciences' PreGen-26(TM) technology, to detect colorectal cancer in people afflicted with the syndrome known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC), is now being made commercially available through both EXACT Sciences and its partner, Laboratory Corporation of America(R) Holdings (LabCorp).